Cargando…
Heparin Anticoagulant for Human Bone Marrow Does Not Influence In Vitro Performance of Human Mesenchymal Stromal Cells
Mesenchymal stromal cells (MSCs) are a promising cell source for tissue engineering and regenerative medicine. In our lab, we found that MSC preparations from bone marrow of many different donors had a limited capacity of in vitro differentiation into osteogenic and chondrogenic lineages—a capacity...
Autores principales: | Roger, Yvonne, Burmeister, Laura, Hamm, Anika, Elger, Kirsten, Dittrich-Breiholz, Oliver, Flörkemeier, Thilo, Hoffmann, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408646/ https://www.ncbi.nlm.nih.gov/pubmed/32610653 http://dx.doi.org/10.3390/cells9071580 |
Ejemplares similares
-
The inflammatory signalling mediator TAK1 mediates lymphocyte recruitment to lipopolysaccharide-activated murine mesenchymal stem cells through interleukin-6
por: Oelze, Beatrice, et al.
Publicado: (2021) -
Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation
por: Selich, Anton, et al.
Publicado: (2019) -
Human bone marrow stromal cells: the impact of anticoagulants on stem cell properties
por: Ferencakova, Michaela, et al.
Publicado: (2023) -
Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy
por: Liao, Li, et al.
Publicado: (2017) -
Effect of interleukin-1β treatment on co-cultures of human meniscus cells and bone marrow mesenchymal stromal cells
por: Chowdhury, Anika, et al.
Publicado: (2013)